From rehabilitation to remission in ankylosing spondylitis

Reumatismo

Volumn 61, Issue 4, 2009, Pages 241-243

  Lubrano, E ^a   Spadaro, Antonio ^b  

^a IRCCS   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2 INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR INHIBITOR;

ANKYLOSING SPONDYLITIS; DISEASE ACTIVITY; DISEASE COURSE; DRUG EFFICACY; EDITORIAL; EDUCATION; HUMAN; INFLAMMATION; MUSCULOSKELETAL DISEASE; PHYSIOTHERAPY; QUALITY OF LIFE; REHABILITATION CARE; REMISSION; SPINE FUSION; SPINE MOBILITY; THERAPY EFFECT;

HUMANS; REMISSION INDUCTION; SPONDYLITIS, ANKYLOSING;

EID: 75749126571     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (26)

1. Zochling J, van der Heijde D, Burgos Vargas R, Collantes E, Davis Jr JC, Dijkmans B, et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis; 2006; 65: 442-52.
2. Zochling J, Bohl-Buhler MH, Baraliakos X, Feldtkeller E, Braun J. Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis - a population - based survey. Clin Rheumatol 2006; 25: 794-800.
3. Wanders A, Heijde D, Landewé R, Béhier JM, Calin A, Olivieri I, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 2005; 52: 1756-65.
4. Ward MM. Prospects for disease modification in ankylosing spondylitis: do nonsteroidal anti-inflammatory drugs more than treat symptoms? Arthritis Rheum 2005; 52: 1634-6.
5. Chen J, Liu C, Lin J. Methotrexate for ankylosing spondylitis. The Cochrane Database of Systematic Reviewes 2006, Issue 4. Art. No.: CD004524. DOI: 10.1002/14651858.CD004524.pub3.
6. Haibel H, Brandt HC, Song IH, Brandt A, Listing J, Rudwaleit M, et al. No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial. Ann Rheum Dis 2007; 66: 419-21.
7. Smith JA, Märker-Hermann E, Colbert RA. Pathogenesis of ankylosing spondylitis: current concepts. Best Pract Res Clin Rheumatol 2006; 20: 571-91.
8. Mcleod C, Bagust A, Boland A, Dagenais P, Dickson R, Dundar Y, et al. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. Health Technol Assess 2007; 11: 1-158.
9. van der Heijde D, Salonen D, Weissman BN, Landewé R, MaksymowychWP, Kupper H, et al. Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years. Arthritis Res Ther 2009; 11: R127.
10. van der Heijde D, Landewé R, Einstein S, Ory P, Vosse D, Ni L, et al. Radiographic progression of ankylosing spondylitis after up two years of treatment with etanercpet. Arthritis Rheum 2008; 58: 1324- 31.
11. van der Heijde D, Landewé R, Baraliakos X, Hoube H, van Tubergen A, Williamson P, et al. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 2008; 58: 3063-70.
12. Dagfinrud H, Kvien TK, Hagen KB. Physiotherapy interventions for ankylosing spondylitis. The Cochrane Database of Systematic Reviewes 2007, Issue 4. Art. No.: CD002822. DOI: 10.1002/14651858. CD002822.pub2.
13. van der Linden S, van Tubergen A, Hidding A. Physiotherapy in ankylosing spondylitis: what is the evidence? Clin Exp Rheumatol 2002; 20 (6 Suppl 28): S60-4.
14. Analay Y, Ozcan E, Karan A, Diracoglu D, Aydin R. The effectiveness of intensive group exercise on patients with ankylosing spondylitis. Clin Rehabil 2003; 17: 631-6.
15. Nghiem FT, Donohue JP. Rehabilitation in ankylosing spondylitis. Curr Opin Rheumatol 2008; 20: 203-7.
16. Elyan M, Khan MA. Does physical therapy still have a place in the treatment of ankylosing spondylitis? Curr Opin Rheumatol 2008; 20: 282-6.
17. Lim HJ, Moon YI, Lee SM. Effects of home-based daily exercise therapy o joint mobility, daily activity, pain, and depression in patients with ankylosing spondylitis. Rheumatol Int 2005; 25: 225-9.
18. van Tubergen A, Landewe R, van der Heijde D, Hidding A, Wolter N, Asscher M, et al. Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum 2001; 45: 430-8.
19. Viitanen JV, Suni J, Kautiainen H, Liimatainen M, Takala H. Effect of physiotherapy on spinal mobility in ankylosing spondylitis. Scand J Rheumatol 1992; 21: 38-41.
20. Helliwell PS, Abbot CA, Chamberlain MA. A randomised trial of three different physiotherapy regimes in ankylosing spondylitis. Physiotherapy 1996; 82: 85-90.
21. Kraag G, Stokes B, Groh J, Helewa A, Goldsmith CH. The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis - an 8-months follow up. J Rheumatol 1994; 21: 261-3.
22. Lubrano E, Helliwell P. Deterioration in anthropometric measures over six years in patients with ankylosing spondylitis. An initial comparison with disease duration and reported exercise frequency. Physiotherapy 1999; 85: 138-43.
23. Lubrano E, D'Angelo S, Parsons WJ, Corbi G, Ferrara N, Rengo F, et al. Effectiveness of rehabilitation in active ankylosing spondylitis assessed by the ASAS response criteria. Rheumatology 2007; 46: 1672-5.
24. Lubrano E, D'Angelo S, Parsons WJ, Serino F, Tanzillo AT, Olivieri I, et al. Effects of a combination treatment of an intensive rehabilitation program and etanercept in patients with ankylosing spondylitis: a pilot study. J Rheumatol 2006; 33: 2029-34.
25. Spadaro A, De Luca T, Massimiani MP, Ceccarelli F, Riccieri, Valesini G. Occupational therapy in ankylosing spondylitis: short term prospective study in patients treated with anti TNF alpha drugs. Joint Bone Spine 2008; 75: 29-33.
26. Dubey SG, Leeder J, Gaffney K. Physical therapy in anti TNF treated patients with ankylosing spondylitis. Rheumatology 2008; 47: 481-3.